Ankur Shah1, Vinayak Kumar2, Matthew B Palmer2,3, Jennifer Trofe-Clark1,2,4, Benjamin Laskin2,5, Deirdre Sawinski1,2, Jonathan J Hogan1,2. 1. Division of Nephrology, University of Pennsylvania, Philadelphia, Pennsylvania. 2. Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 3. Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania. 4. Department of Pharmacy Services, Hospital of the University of Pennsylvania, University of Pennsylvania, Philadelphia, Pennsylvania. 5. Division of Nephrology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
BACKGROUND: There is a growing base of literature describing BK nephropathy (BKVN) in patients outside of the setting of kidney transplant. Previous systematic reviews of the literature have been limited by methodology or by the scope of patients included. STUDY DESIGN AND METHODS: Systematic Review (Prospero # CRD42018088524). SETTING & POPULATION: Patients without kidney transplant who had biopsy-proven BKVN. SELECTION CRITERIA FOR STUDIES: Full-text articles that describe native BKVN patient cases. ANALYTICAL APPROACH: Descriptive synthesis. RESULTS: The search identified 630 unique articles of which 51 were included in the final review. Sixty-five cases (including two new cases presented in this review) were identified, all but one occurred in the setting of known immunosuppression. LIMITATIONS: The primary limitation was the exclusion of studies that did not fulfill the stringent review criteria. We excluded reports with only a clinical diagnosis of BKVN, such as those with viruria and/or viremia without biopsy. CONCLUSIONS: As of May 2018, there are 65 reported cases of BKVN in native kidneys. This represents the most comprehensive description of biopsy-proven BKVN in native kidneys to date. Evaluation for BK nephropathy should be considered in immunocompromised patients who exhibit unexplained renal failure.
BACKGROUND: There is a growing base of literature describing BK nephropathy (BKVN) in patients outside of the setting of kidney transplant. Previous systematic reviews of the literature have been limited by methodology or by the scope of patients included. STUDY DESIGN AND METHODS: Systematic Review (Prospero # CRD42018088524). SETTING & POPULATION: Patients without kidney transplant who had biopsy-proven BKVN. SELECTION CRITERIA FOR STUDIES: Full-text articles that describe native BKVN patient cases. ANALYTICAL APPROACH: Descriptive synthesis. RESULTS: The search identified 630 unique articles of which 51 were included in the final review. Sixty-five cases (including two new cases presented in this review) were identified, all but one occurred in the setting of known immunosuppression. LIMITATIONS: The primary limitation was the exclusion of studies that did not fulfill the stringent review criteria. We excluded reports with only a clinical diagnosis of BKVN, such as those with viruria and/or viremia without biopsy. CONCLUSIONS: As of May 2018, there are 65 reported cases of BKVN in native kidneys. This represents the most comprehensive description of biopsy-proven BKVN in native kidneys to date. Evaluation for BK nephropathy should be considered in immunocompromised patients who exhibit unexplained renal failure.
Authors: C E H Barber; T J C Hewlett; L Geldenhuys; B A Kiberd; P D Acott; T F Hatchette Journal: Transpl Infect Dis Date: 2006-06 Impact factor: 2.228
Authors: Benedetto Bruno; Richard A Zager; Michael J Boeckh; Theodore A Gooley; David H Myerson; Meei-Li Huang; Robert C Hackman Journal: Transplantation Date: 2004-04-15 Impact factor: 4.939
Authors: B Loeches; M Valerio; M Pérez; R Bañares; J Ledesma; M Fogeda; M Salcedo; D Rincón; E Bouza; P Muñoz Journal: Transplant Proc Date: 2009-04 Impact factor: 1.066
Authors: Michael Oellerich; Karen Sherwood; Paul Keown; Ekkehard Schütz; Julia Beck; Johannes Stegbauer; Lars Christian Rump; Philip D Walson Journal: Nat Rev Nephrol Date: 2021-05-24 Impact factor: 28.314
Authors: Elizabeth M Holland; Corina Gonzalez; Elliot Levy; Vladimir A Valera; Heather Chalfin; Jacquelyn Klicka-Skeels; Bonnie Yates; David E Kleiner; Colleen Hadigan; Hema Dave; Haneen Shalabi; Dennis D Hickstein; Helen C Su; Michael Grimley; Alexandra F Freeman; Nirali N Shah Journal: Front Immunol Date: 2021-12-17 Impact factor: 7.561
Authors: Christophe Masset; Paul Le Turnier; Céline Bressollette-Bodin; Karine Renaudin; François Raffi; Jacques Dantal Journal: Int J Mol Sci Date: 2022-10-10 Impact factor: 6.208